Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics-Reference-Cited by-同舟云学术

Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics

Published:2019 Issue:11 Volume:48 Page:2967-3014
ISSN:0306-0012
Container-title:Chemical Society Reviews
language:en
Short-container-title:Chem. Soc. Rev.

Author:

Tang Wei¹²³⁴⁵,Fan Wenpei¹²³⁴⁵,Lau Joseph¹²³⁴⁵,Deng Liming¹²³⁴⁵,Shen Zheyu¹²³⁴⁵,Chen Xiaoyuan¹²³⁴⁵^ORCID

Affiliation:

1. Laboratory of Molecular Imaging and Nanomedicine (LOMIN)

2. National Institute of Biomedical Imaging and Bioengineering (NIBIB)

3. National Institutes of Health (NIH)

4. Bethesda

5. USA

Abstract

The advancements, perspectives, and challenges in blood–brain-barrier (BBB)-crossing nanotechnology for effective brain tumor delivery and highly efficient brain cancer theranostics.

Funder

National Institute of Biomedical Imaging and Bioengineering

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/CS/C8CS00805A

Reference293 articles.

1. Cancer statistics, 2019

2. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

3. Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

4. Epidemiology of Brain Metastases

5. The biology of brain metastases—translation to new therapies

Cited by 429 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA polymer conjugates: Revolutionizing neurological disorder treatment through targeted drug delivery;Next Materials;2025-04

2. Brain-specific targeted delivery of therapeutic agents using metal–organic framework-based nanomedicine;Coordination Chemistry Reviews;2024-09

3. BBB-penetrating magnetoelectric nanoparticles with sustainable Gel formulation for enhanced chemotherapy and reduced postoperative glioma recurrence;Chemical Engineering Journal;2024-09

4. Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood–Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery;Pharmaceuticals;2024-08-15

5. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12